UPDATE 1-Novartis transforms drug business via deals with GSK and Lilly
April 22, 2014 at 02:20 AM EDT
ZURICH, April 22 (Reuters) - Swiss drugmaker Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly in deals worth billions of dollars.
